Reuters logo
BRIEF-Akcea Q2 loss per share $0.41
2017年8月8日 / 上午11点16分 / 3 个月前

BRIEF-Akcea Q2 loss per share $0.41

Aug 8 (Reuters) - Akcea Therapeutics Inc:

* Akcea reports financial results and highlights for second quarter 2017

* Q2 loss per share $0.41

* Akcea Therapeutics Inc - ‍expects its g&a expenses to continue to increase as company continues to prepare to launch volanesorsen​

* Akcea Therapeutics Inc - ‍Akcea’s revenue for three ended june 30, 2017 was $14.1 million​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below